Skip to main content
. 2011 Oct 28;1:36. doi: 10.3389/fonc.2011.00036

Table 2.

Pre-temozolomide trials.

Author N Schema Results
Souhami et al. (2004) 203 60 Gy RT versus 60 Gy RT+SRS, both with concurrent BCNU No difference in median survival
Buckner et al. (2006) 401 64.8 Gy RT versus accelerated RT, both with BCNU +/− cisplatin No improvement in survival with accelerated RT or addition of cisplatin
Fisher et al. (2002) 87 60 Gy RT with topotecan Median survival 9 months
Langer et al. (2001) 61 60 Gy RT with paclitaxel Median survival 10 months